XML 34 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equity Method Investment in Common Stock of Asterias, at fair value (Tables)
 6 Months Ended
Jun. 30, 2016
Equity Method Investment in Common Stock of Asterias, at fair value [Abstract]  
Unaudited condensed financial statements information and operations
The unaudited condensed results of operations and unaudited condensed balance sheet information of Asterias are summarized below (in thousands):

  
Three months ended June 30, 2016
  
Six months ended June 30, 2016
  
For the Period
May 13, 2016 through
June 30, 2016 (2)
 
Condensed Statements of Operations (1):
         
Total revenue
 
$
1,532
  
$
3,126
  $
772
 
Gross profit
  
1,526
   
3,067
   
766
 
Loss from operations
  
(7,074
)
  
(18,166
)
  
(4,134
)
Net loss
 
$
(5,159
)
 
$
(15,946
)
 $
(2,383
)

  
June 30, 2016
  
December 31, 2015
 
Condensed Balance Sheet information (1):
      
Current assets
 
$
33,830
  
$
12,783
 
Noncurrent assets
  
33,414
   
27,445
 
  
$
67,244
  
$
40,228
 
         
Current liabilities
 
$
13,219
  
$
4,450
 
Noncurrent liabilities
  
10,751
   
4,605
 
Stockholders’ equity
  
43,274
   
31,173
 
  
$
67,244
  
$
40,228
 

(1) The condensed unaudited statement of operations information included in the table above reflects Asterias’ results of operations for the three and six months ended June 30, 2016.  Asterias unaudited results of operations for the period from January 1, 2016 through May 12, 2016, the date immediately preceding the Deconsolidation, are included in the unaudited consolidated results of operations of BioTime for the three and six months ended June 30, 2016 shown in the table below.  The condensed unaudited balance sheet information of Asterias included in the table above was included in BioTime’s consolidated balance sheet at December 31, 2015, after intercompany eliminations.
 
(2) The condensed unaudited statement of operations information for the period May 13, 2016 through June 30, 2016 is not included in the unaudited consolidated results of BioTime for the three and six months ended June 30, 2016 due to the Deconsolidation of Asterias on May 13, 2016.
The following table summarizes Asterias’ unaudited results of operations that are included in BioTime’s unaudited consolidated results of operations, after intercompany eliminations, for the period from January 1, 2016 through May 12, 2016, the date immediately preceding the deconsolidation of Asterias, the period from April 1, 2016 through May 12, 2016 and, for the three and six months ended June 30, 2015 (unaudited) (in thousands).

  
For the Period April 1, 2016 through May 12, 2016
  
Three months ended June 30, 2015
  
For the Period January 1, 2016 through May 12, 2016
  
Six months ended June 30, 2015
 
Total revenue
 
$
760
  
$
772
  
$
2,354
  
$
1,552
 
Gross profit
  
760
   
734
   
2,301
   
1,464
 
Loss from operations
  
(2,940
)
  
(4,807
)
  
(14,032
)
  
(9,342
)
Net loss
 
$
(2,776
)
 
$
(3,618
)
 
$
(13,113
)
 
$
(6,590
)